UA75369C2 - Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon - Google Patents

Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon Download PDF

Info

Publication number
UA75369C2
UA75369C2 UA2003043896A UA2003043896A UA75369C2 UA 75369 C2 UA75369 C2 UA 75369C2 UA 2003043896 A UA2003043896 A UA 2003043896A UA 2003043896 A UA2003043896 A UA 2003043896A UA 75369 C2 UA75369 C2 UA 75369C2
Authority
UA
Ukraine
Prior art keywords
group
compounds
compounds according
trifluoromethyl
salts
Prior art date
Application number
UA2003043896A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of UA75369C2 publication Critical patent/UA75369C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/20Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C309/22Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
UA2003043896A 2000-09-26 2001-09-13 Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon UA75369C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10047486A DE10047486A1 (de) 2000-09-26 2000-09-26 Phenoxyphenyl Alkansulfonate
PCT/EP2001/010564 WO2002026702A1 (de) 2000-09-26 2001-09-13 Phenoxyphenyl alkansulfonate

Publications (1)

Publication Number Publication Date
UA75369C2 true UA75369C2 (en) 2006-04-17

Family

ID=7657564

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2003043896A UA75369C2 (en) 2000-09-26 2001-09-13 Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon

Country Status (34)

Country Link
US (2) US6756409B2 (no)
EP (1) EP1334086B1 (no)
JP (1) JP2004509946A (no)
KR (1) KR20030039372A (no)
CN (1) CN1476427A (no)
AR (1) AR033575A1 (no)
AT (1) ATE292621T1 (no)
AU (2) AU2002220547B2 (no)
BG (1) BG107634A (no)
BR (1) BR0114182A (no)
CA (1) CA2423171A1 (no)
DE (2) DE10047486A1 (no)
EE (1) EE200300117A (no)
ES (1) ES2240543T3 (no)
GT (1) GT200100193A (no)
HN (1) HN2001000214A (no)
HR (1) HRP20030326A2 (no)
HU (1) HUP0302258A3 (no)
IL (1) IL154968A0 (no)
MA (1) MA26053A1 (no)
MX (1) MXPA03002546A (no)
NO (1) NO20031357D0 (no)
NZ (1) NZ524886A (no)
PE (1) PE20020408A1 (no)
PL (1) PL361015A1 (no)
PT (1) PT1334086E (no)
RU (1) RU2278853C2 (no)
SI (1) SI1334086T1 (no)
SK (1) SK3442003A3 (no)
SV (1) SV2002000639A (no)
UA (1) UA75369C2 (no)
UY (1) UY26945A1 (no)
WO (1) WO2002026702A1 (no)
ZA (1) ZA200302275B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061699A1 (en) * 2001-12-27 2003-07-31 Japan Tobacco, Inc. Remedies for allergic diseases
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
CN102149379A (zh) 2008-07-10 2011-08-10 安吉翁生物医药有限公司 调节肝细胞生长因子(分散因子)活性的方法和肝细胞生长因子(分散因子)活性的小分子调节剂组合物
US10709497B2 (en) * 2017-09-22 2020-07-14 Covidien Lp Electrosurgical tissue sealing device with non-stick coating
EP3927702A4 (en) 2019-04-11 2022-05-11 Angion Biomedica Corp. SOLID FORMS OF (E)-3-[2-(2-THIENYL)VINYL]-1H-PYRAZOLE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE216642C (no) *
BE786644A (fr) * 1971-07-23 1973-01-24 Hoechst Ag Derives d'acides phenoxy-4 phenoxy-alcane-carboxyliques leur preparation et les medicaments qui en contiennent
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
GB8914660D0 (en) * 1989-06-26 1989-08-16 Fujisawa Pharmaceutical Co Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same
MY117939A (en) * 1996-07-25 2004-08-30 Lg Chemical Ltd Composition for enhancing oral hygiene
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
AU735137B2 (en) * 1997-02-21 2001-07-05 Bayer Intellectual Property Gmbh Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
DK1031556T3 (da) * 1997-10-20 2003-02-24 Taisho Pharmaceutical Co Ltd 2-phenoxyanilinderivater
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
NL1008795C2 (nl) * 1998-04-02 1999-10-05 Rene Werenfridus Lodewijk Vroo Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling.
DE19837627A1 (de) * 1998-08-19 2000-02-24 Bayer Ag Neue Aminosäureester von Arylsulfonamiden und Analoga
HN1998000027A (es) * 1998-08-19 1999-06-02 Bayer Ip Gmbh Arilsulfonamidas y analagos
US6242422B1 (en) * 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases

Also Published As

Publication number Publication date
DE10047486A1 (de) 2002-04-11
SK3442003A3 (en) 2003-10-07
ATE292621T1 (de) 2005-04-15
BR0114182A (pt) 2003-07-29
HRP20030326A2 (en) 2005-02-28
DE50105857D1 (de) 2005-05-12
KR20030039372A (ko) 2003-05-17
CN1476427A (zh) 2004-02-18
AU2002220547B2 (en) 2006-11-02
SV2002000639A (es) 2002-10-24
CA2423171A1 (en) 2003-03-21
EP1334086B1 (de) 2005-04-06
NO20031357L (no) 2003-03-25
NZ524886A (en) 2005-09-30
UY26945A1 (es) 2002-04-26
SI1334086T1 (en) 2005-10-31
PT1334086E (pt) 2005-08-31
US20030022934A1 (en) 2003-01-30
AU2054702A (en) 2002-04-08
HUP0302258A3 (en) 2006-02-28
IL154968A0 (en) 2003-10-31
PL361015A1 (en) 2004-09-20
US6756409B2 (en) 2004-06-29
HN2001000214A (es) 2001-10-25
NO20031357D0 (no) 2003-03-25
EP1334086A1 (de) 2003-08-13
RU2278853C2 (ru) 2006-06-27
WO2002026702A1 (de) 2002-04-04
JP2004509946A (ja) 2004-04-02
AR033575A1 (es) 2003-12-26
GT200100193A (es) 2002-06-04
HUP0302258A2 (hu) 2003-11-28
EE200300117A (et) 2005-04-15
MA26053A1 (fr) 2004-04-01
US20040214886A1 (en) 2004-10-28
MXPA03002546A (es) 2004-04-20
BG107634A (bg) 2003-12-31
ZA200302275B (en) 2004-03-24
PE20020408A1 (es) 2002-06-08
ES2240543T3 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
TWI233436B (en) Benzoxazinones in combination with other agents as inhibitors of HIV reverse transcriptase
JP2020186242A (ja) フッ化硫黄(vi)化合物およびそれの製造方法
JP5302398B2 (ja) 置換アミノテトラリン
TW202204323A (zh) 經取代之嗒𠯤化合物
US8389538B2 (en) Rexinoid compound having alkoxy group
JP2001525406A (ja) 新規な化合物
KR20050044657A (ko) mGluR5 안타고니스트 활성을 갖는 아세틸렌 유도체
JPH11503116A (ja) 二環式アミン誘導体および抗精神病薬としてのそれらの使用
US8791106B2 (en) Fused ring pyridine compound
TW201116281A (en) N atom containing ring acylguanidine derivatives
AU2020256301A1 (en) Fused bicyclic compounds for the treatment of disease
KR20130094311A (ko) P2x4 수용체 길항제
US20180065936A1 (en) Therapeutic compounds
UA75369C2 (en) Phenoxyphenyl alkane sulfonates, a method for the preparation thereof and medicament based thereon
JP2011506551A (ja) Ampa受容体増強化合物および医薬におけるその使用
CN116655557B (zh) 苯并噻唑类化合物、其制备方法及应用
US12297193B2 (en) PTPN2/PTP1B degrader and therapeutic method thereof
JPS63165362A (ja) 置換アミノチメル−5,6,7,8−テトラヒドロナフチルオキシ酢酸類、中間体類、それらの製造法および薬物におけるそれらの使用
US20090170902A1 (en) Compounds which potentiate glutamate receptor and uses thereof in medicine
JP3110049B2 (ja) 新規イミダゾールリポキシゲナーゼ阻害剤
JPH08134030A (ja) ベンゾシクロアルケン類、その製造法および剤
WO2026026968A1 (zh) 一种含芳香稠环的化合物、其药物组合物和应用
CN118420529A (zh) 新型雌激素受体下调剂化合物、制备方法及用途
US20210363109A1 (en) Phenyl cyclohexanone derivatives and methods of making and using them
JPH054986A (ja) ピラゾロキノリン誘導体